- Home
- RLMD vs HKPD Comparison
RLMD vs HKPD Comparison
Compare RLMD & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- HKPD
- Stock Information
- Founded
- RLMD 2004
- HKPD 2016
- Country
- RLMD United States
- HKPD Hong Kong
- Employees
- RLMD N/A
- HKPD N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- HKPD Other Pharmaceuticals
- Sector
- RLMD Health Care
- HKPD Health Care
- Exchange
- RLMD Nasdaq
- HKPD Nasdaq
- Market Cap
- RLMD 11.5M
- HKPD 11.9M
- IPO Year
- RLMD N/A
- HKPD 2025
- Fundamental
- Price
- RLMD $0.40
- HKPD $1.01
- Analyst Decision
- RLMD Hold
- HKPD
- Analyst Count
- RLMD 4
- HKPD 0
- Target Price
- RLMD $4.25
- HKPD N/A
- AVG Volume (30 Days)
- RLMD 4.5M
- HKPD 275.2K
- Earning Date
- RLMD 05-12-2025
- HKPD 01-01-0001
- Dividend Yield
- RLMD N/A
- HKPD N/A
- EPS Growth
- RLMD N/A
- HKPD N/A
- EPS
- RLMD N/A
- HKPD 0.21
- Revenue
- RLMD N/A
- HKPD $20,770,344.00
- Revenue This Year
- RLMD N/A
- HKPD N/A
- Revenue Next Year
- RLMD N/A
- HKPD N/A
- P/E Ratio
- RLMD N/A
- HKPD $5.01
- Revenue Growth
- RLMD N/A
- HKPD 32.91
- 52 Week Low
- RLMD $0.24
- HKPD $0.88
- 52 Week High
- RLMD $4.47
- HKPD $3.79
- Technical
- Relative Strength Index (RSI)
- RLMD 51.73
- HKPD N/A
- Support Level
- RLMD $0.36
- HKPD N/A
- Resistance Level
- RLMD $0.44
- HKPD N/A
- Average True Range (ATR)
- RLMD 0.08
- HKPD 0.00
- MACD
- RLMD -0.00
- HKPD 0.00
- Stochastic Oscillator
- RLMD 26.98
- HKPD 0.00
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.